Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 938

1.

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).

Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL.

J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5.

2.

Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.

Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA.

Diabet Med. 2019 Jul 11. doi: 10.1111/dme.14074. [Epub ahead of print]

PMID:
31295359
3.

Optimizing oncolytic virotherapy in cancer treatment.

Harrington K, Freeman DJ, Kelly B, Harper J, Soria JC.

Nat Rev Drug Discov. 2019 Jul 10. doi: 10.1038/s41573-019-0029-0. [Epub ahead of print] Review.

PMID:
31292532
4.

Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.

Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA.

Diabetes Technol Ther. 2019 Jul 9. doi: 10.1089/dia.2019.0142. [Epub ahead of print]

PMID:
31287721
5.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma.

Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Chan Ahn Y, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT.

Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33428-5. doi: 10.1016/j.ijrobp.2019.06.2540. [Epub ahead of print]

PMID:
31276776
6.

Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21.

Annels NE, Mansfield D, Arif M, Ballesteros-Merino C, Simpson GR, Denyer M, Sandhu SS, Melcher A, Harrington KJ, Davies B, Au G, Grose M, Bagwan IN, Fox BA, Vile RG, Mostafid H, Shafren D, Pandha H.

Clin Cancer Res. 2019 Jul 4. pii: clincanres.4022.2018. doi: 10.1158/1078-0432.CCR-18-4022. [Epub ahead of print]

PMID:
31273010
7.

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21.

Müller LME, Holmes M, Michael JL, Scott GB, West EJ, Scott KJ, Parrish C, Hall K, Stäble S, Jennings VA, Cullen M, McConnell S, Langton C, Tidswell EL, Shafren D, Samson A, Harrington KJ, Pandha H, Ralph C, Kelly RJ, Cook G, Melcher AA, Errington-Mais F.

J Immunother Cancer. 2019 Jul 1;7(1):164. doi: 10.1186/s40425-019-0632-y.

8.

Gender Differences in Demographic and Health Characteristics of the Million Veteran Program Cohort.

Harrington KM, Nguyen XT, Song RJ, Hannagan K, Quaden R, Gagnon DR, Cho K, Deen JE, Muralidhar S, O'Leary TJ, Gaziano JM, Whitbourne SB; VA Million Veteran Program.

Womens Health Issues. 2019 Jun 25;29 Suppl 1:S56-S66. doi: 10.1016/j.whi.2019.04.012.

PMID:
31253243
9.

Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

Haddad R, Concha-Benavente F, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Kasper S, Vokes EE, Worden F, Saba NF, Tahara M, Jayaprakash V, Lynch M, Li L, Gillison ML, Harrington KJ, Ferris RL.

Cancer. 2019 Jun 27. doi: 10.1002/cncr.32190. [Epub ahead of print]

PMID:
31246283
10.

Nivolumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.

Ferris RL, Licitra L, Fayette J, Even C, Blumenschein GR, Harrington KJ, Guigay J, Vokes EE, Saba NF, Haddad RI, Ramkumar S, Russell J, Brossart P, Tahara M, Colevas AD, Concha-Benavente F, Lynch M, Li L, Gillison ML.

Clin Cancer Res. 2019 Jun 25. pii: clincanres.3944.2018. doi: 10.1158/1078-0432.CCR-18-3944. [Epub ahead of print]

PMID:
31239321
11.

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing.

Kempker RR, Chkhartishvili N, Kinkladze I, Schechter MC, Harrington K, Rukhadze N, Dzigua L, Tserstvadze T, Del Rio C, Blumberg HM, Tukvadze N.

Open Forum Infect Dis. 2019 May 17;6(6):ofz233. doi: 10.1093/ofid/ofz233. eCollection 2019 Jun.

12.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
13.

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.

Andtbacka RHI, Collichio F, Harrington KJ, Middleton MR, Downey G, Ӧhrling K, Kaufman HL.

J Immunother Cancer. 2019 Jun 6;7(1):145. doi: 10.1186/s40425-019-0623-z.

14.

Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk Loci.

Gelernter J, Sun N, Polimanti R, Pietrzak RH, Levey DF, Lu Q, Hu Y, Li B, Radhakrishnan K, Aslan M, Cheung KH, Li Y, Rajeevan N, Sayward F, Harrington K, Chen Q, Cho K, Honerlaw J, Pyarajan S, Lencz T, Quaden R, Shi Y, Hunter-Zinck H, Gaziano JM, Kranzler HR, Concato J, Zhao H, Stein MB; Department of Veterans Affairs Cooperative Studies Program (No. 575B) and Million Veteran Program.

Biol Psychiatry. 2019 Apr 8. pii: S0006-3223(19)31156-4. doi: 10.1016/j.biopsych.2019.03.984. [Epub ahead of print]

PMID:
31151762
15.

Low cost 235 nm ultra-violet light-emitting diode-based absorbance detector for application in a portable ion chromatography system for nitrite and nitrate monitoring.

Murray E, Roche P, Harrington K, McCaul M, Moore B, Morrin A, Diamond D, Paull B.

J Chromatogr A. 2019 May 21. pii: S0021-9673(19)30542-4. doi: 10.1016/j.chroma.2019.05.036. [Epub ahead of print]

PMID:
31151694
16.

High fidelity fibre-based physiological sensing deep in tissue.

Choudhary TR, Tanner MG, Megia-Fernandez A, Harrington K, Wood HA, Marshall A, Zhu P, Chankeshwara SV, Choudhury D, Monro G, Ucuncu M, Yu F, Duncan RR, Thomson RR, Dhaliwal K, Bradley M.

Sci Rep. 2019 May 22;9(1):7713. doi: 10.1038/s41598-019-44077-7.

17.

Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: a cross-sectional analysis of the REGARDS study.

Parekh TM, Wu C, McClure LA, Howard VJ, Cushman M, Malek AM, Harrington KF, Cherrington AL, Dransfield MT, Bhatia S.

BMJ Open. 2019 May 10;9(5):e027175. doi: 10.1136/bmjopen-2018-027175.

18.

Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED).

John C, Reeve NF, Free RC, Williams AT, Farmaki AE, Bethea J, Barton LM, Shrine N, Batini C, Packer R, Terry S, Hargadon B, Wang Q, Melbourne CA, Adams EL, Bee CE, Harrington K, Miola J, Brunskill NJ, Brightling CE, Barwell J, Wallace SE, Hsu R, Shepherd DJ, Hollox EJ, Wain LV, Tobin MD.

Int J Epidemiol. 2019 May 7. pii: dyz073. doi: 10.1093/ije/dyz073. [Epub ahead of print] No abstract available.

PMID:
31062032
19.

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition.

Jennings VA, Scott GB, Rose AMS, Scott KJ, Migneco G, Keller B, Reilly K, Donnelly O, Peach H, Dewar D, Harrington KJ, Pandha H, Samson A, Vile RG, Melcher AA, Errington-Mais F.

Mol Ther. 2019 Jun 5;27(6):1139-1152. doi: 10.1016/j.ymthe.2019.04.008. Epub 2019 Apr 14.

20.

Validation of an Electronic Medical Record-Based Algorithm for Identifying Posttraumatic Stress Disorder in U.S. Veterans.

Harrington KM, Quaden R, Stein MB, Honerlaw JP, Cissell S, Pietrzak RH, Zhao H, Radhakrishnan K, Aslan M, Gaziano JM, Concato J, Gagnon DR, Gelernter J, Cho K; VA Million Veteran Program and Cooperative Studies Program.

J Trauma Stress. 2019 Apr;32(2):226-237. doi: 10.1002/jts.22399.

PMID:
31009556
21.

Principal component analysis fosr fast and model-free denoising of multi b-value diffusion-weighted MR images.

Gurney-Champion OJ, Collins DJ, Wetscherek A, Rata M, Klaassen R, van Laarhoven HWM, Harrington KJ, Oelfke U, Orton MR.

Phys Med Biol. 2019 May 17;64(10):105015. doi: 10.1088/1361-6560/ab1786.

PMID:
30965296
22.

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment.

Evgin L, Huff AL, Kottke T, Thompson J, Molan AM, Driscoll CB, Schuelke M, Shim KG, Wongthida P, Ilett EJ, Smith KK, Harris RS, Coffey M, Pulido JS, Pandha H, Selby PJ, Harrington KJ, Melcher A, Vile RG.

Cancer Immunol Res. 2019 May;7(5):828-840. doi: 10.1158/2326-6066.CIR-18-0013. Epub 2019 Apr 2.

PMID:
30940643
23.

Escalation of Memory Length in Finite Populations.

Harrington K, Pollack J.

Artif Life. 2019 Winter;25(1):22-32. doi: 10.1162/artl_a_00278.

PMID:
30933630
24.

Use of Patient-Reported Outcome Measures in Athletic Training: Common Measures, Selection Considerations, and Practical Barriers.

Lam KC, Harrington KM, Cameron KL, Valier ARS.

J Athl Train. 2019 Apr;54(4):449-458. doi: 10.4085/1062-6050-108-17. Epub 2019 Apr 1.

PMID:
30933607
25.

Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.

Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P for the AIBL Research Group.

J Clin Exp Neuropsychol. 2019 Aug;41(6):591-600. doi: 10.1080/13803395.2019.1593949. Epub 2019 Mar 29.

PMID:
30924399
26.

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.

Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ.

Sci Transl Med. 2019 Mar 27;11(485). pii: eaau7746. doi: 10.1126/scitranslmed.aau7746.

PMID:
30918115
27.

Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations.

Yavuz B, Zeki J, Taylor J, Harrington K, Coburn JM, Ikegaki N, Kaplan DL, Chiu B.

J Pharm Sci. 2019 Aug;108(8):2748-2755. doi: 10.1016/j.xphs.2019.03.019. Epub 2019 Mar 21.

PMID:
30905702
28.

Improving Attitudes and Perceptions About End-of-Life Nursing on a Hospital-Based Palliative Care Unit.

Harrington KJ, Affronti ML, Schneider SM, Razzak AR, Smith TJ.

J Hosp Palliat Nurs. 2019 Aug;21(4):272-279. doi: 10.1097/NJH.0000000000000523.

PMID:
30893285
29.

PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma.

Smith HG, Mansfield D, Roulstone V, Kyula-Currie JN, McLaughlin M, Patel RR, Bergerhoff KF, Paget JT, Dillon MT, Khan A, Melcher A, Thway K, Harrington KJ, Hayes AJ.

Clin Cancer Res. 2019 Jun 1;25(11):3443-3454. doi: 10.1158/1078-0432.CCR-18-3767. Epub 2019 Mar 18.

PMID:
30885937
30.

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention.

Yavuz B, Morgan JL, Herrera C, Harrington K, Perez-Ramirez B, LiWang PJ, Kaplan DL.

J Control Release. 2019 May 10;301:1-12. doi: 10.1016/j.jconrel.2019.03.001. Epub 2019 Mar 12.

PMID:
30876951
31.

Radiotherapy enhances responses of lung cancer to CTLA-4 blockade.

Wilkins A, McDonald F, Harrington K, Melcher A.

J Immunother Cancer. 2019 Mar 6;7(1):64. doi: 10.1186/s40425-019-0542-z.

32.

Multi-sample SPIM image acquisition, processing and analysis of vascular growth in zebrafish.

Daetwyler S, Günther U, Modes CD, Harrington K, Huisken J.

Development. 2019 Mar 21;146(6). pii: dev173757. doi: 10.1242/dev.173757.

33.

Quality Improvement Project to Improve Screening for Tobacco Use in Adolescent Inpatients at a Children's Hospital.

Wagner LA, Molina AL, Grizzle K, Hofto ME, Nassetta LB, Orr MM, Samuy N, Schmit EO, Smola C, Harrington KF, Walley SC.

Children (Basel). 2019 Feb 28;6(3). pii: E37. doi: 10.3390/children6030037.

34.

Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.

Moy ML, Harrington KF, Sternberg AL, Krishnan JA, Albert RK, Au DH, Casaburi R, Criner GJ, Diaz P, Kanner RE, Panos RJ, Stibolt T, Stoller JK, Tonascia J, Yusen RD, Tan AM, Fuhlbrigge AL; LOTT Research Group.

Respir Med. 2019 Mar;149:52-58. doi: 10.1016/j.rmed.2019.02.004. Epub 2019 Feb 13.

PMID:
30803886
35.

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment.

Dillon MT, Bergerhoff KF, Pedersen M, Whittock H, Crespo-Rodriguez E, Patin EC, Pearson A, Smith HG, Paget JTE, Patel RR, Foo S, Bozhanova G, Ragulan C, Fontana E, Desai K, Wilkins AC, Sadanandam A, Melcher A, McLaughlin M, Harrington KJ.

Clin Cancer Res. 2019 Jun 1;25(11):3392-3403. doi: 10.1158/1078-0432.CCR-18-1821. Epub 2019 Feb 15.

PMID:
30770349
36.

Genomics of posttraumatic stress disorder in veterans: Methods and rationale for Veterans Affairs Cooperative Study #575B.

Radhakrishnan K, Aslan M, Harrington KM, Pietrzak RH, Huang G, Muralidhar S, Cho K, Quaden R, Gagnon D, Pyarajan S, Sun N, Zhao H, Gaziano M, Concato J, Stein MB, Gelernter J.

Int J Methods Psychiatr Res. 2019 Mar;28(1):e1767. doi: 10.1002/mpr.1767. Epub 2019 Feb 14.

PMID:
30767326
37.

Effect on herbicide adsorption of organic forestry waste products used for soil remediation.

James TK, Ghanizadeh H, Harrington KC, Bolan NS.

J Environ Sci Health B. 2019;54(5):407-415. doi: 10.1080/03601234.2019.1574170. Epub 2019 Feb 7.

PMID:
30729862
38.

Hospital Onset Varicella Central Nervous System Vasculitis in a Patient with HIV Infection.

Harrington KRV, Rhyner P, Kempker RR.

AIDS Res Hum Retroviruses. 2019 Apr;35(4):357-358. doi: 10.1089/aid.2018.0262. Epub 2019 Feb 4. No abstract available.

PMID:
30715900
39.

Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe.

Gutzmer R, Harrington KJ, Hoeller C, Lebbé C, Malvehy J, Öhrling K, Downey G, Dummer R.

Eur J Dermatol. 2018 Dec 1;28(6):736-749. doi: 10.1684/ejd.2018.3447. Review.

PMID:
30698145
40.

Artificial Gene Regulatory Networks-A Review.

Cussat-Blanc S, Harrington K, Banzhaf W.

Artif Life. 2018 Fall;24(4):296-328. doi: 10.1162/artl_a_00267. Epub 2019 Jan 25.

PMID:
30681915
41.

The immunological consequences of radiation-induced DNA damage.

Wilkins AC, Patin EC, Harrington KJ, Melcher AA.

J Pathol. 2019 Apr;247(5):606-614. doi: 10.1002/path.5232. Epub 2019 Feb 15. Review.

PMID:
30632153
42.

Acquisition and reconstruction of 4D surfaces of axolotl embryos with the flipping stage robotic microscope.

Crawford-Young SJ, Dittapongpitch S, Gordon R, Harrington KIS.

Biosystems. 2018 Nov;173:214-220. doi: 10.1016/j.biosystems.2018.10.006. Epub 2018 Oct 25.

PMID:
30554603
43.

Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.

Dintzis SM, Hansen S, Harrington KM, Tan LC, Miller DM, Ishak L, Parrish-Novak J, Kittle D, Perry J, Gombotz C, Fortney T, Porenta S, Hales L, Calhoun KE, Anderson BO, Javid SH, Byrd DR.

Arch Pathol Lab Med. 2018 Dec 14. doi: 10.5858/arpa.2018-0197-OA. [Epub ahead of print]

PMID:
30550350
44.

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.

Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators.

Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Erratum in: Lancet. 2019 Jan 12;393(10167):132.

PMID:
30509740
45.

Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review.

Harrington KA, Hoda S, La Rocca Vieira R.

Skeletal Radiol. 2019 May;48(5):823-830. doi: 10.1007/s00256-018-3120-4. Epub 2018 Nov 29. Review.

PMID:
30498967
46.

Electronic Cigarette Awareness, Use, and Perceptions among Cancer Patients.

Buczek EJ, Harrington KF, Hendricks PS, Schmalbach CE.

OTO Open. 2018 May 9;2(2):2473974X18774543. doi: 10.1177/2473974X18774543. eCollection 2018 Apr-Jun.

47.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, Dalby M, Mistry P, Sen M, O'Toole L, Al Booz H, Dyker K, Moleron R, Whitaker S, Brennan S, Cook A, Griffin M, Aynsley E, Rolles M, De Winton E, Chan A, Srinivasan D, Nixon I, Grumett J, Leemans CR, Buter J, Henderson J, Harrington K, McConkey C, Gray A, Dunn J; De-ESCALaTE HPV Trial Group.

Lancet. 2019 Jan 5;393(10166):51-60. doi: 10.1016/S0140-6736(18)32752-1. Epub 2018 Nov 15.

48.

Fitness costs associated with multiple resistance to dicamba and atrazine in Chenopodium album.

Ghanizadeh H, Harrington KC.

Planta. 2019 Mar;249(3):787-797. doi: 10.1007/s00425-018-3040-5. Epub 2018 Nov 7.

PMID:
30406410
49.

Association of community food environment and obesity among US adults: a geographical information system analysis.

Chen M, Creger T, Howard V, Judd SE, Harrington KF, Fontaine KR.

J Epidemiol Community Health. 2019 Feb;73(2):148-155. doi: 10.1136/jech-2018-210838. Epub 2018 Nov 5.

PMID:
30397025
50.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.

Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 24;13:19-23. doi: 10.1016/j.ctro.2018.08.003. eCollection 2018 Nov.

Supplemental Content

Loading ...
Support Center